LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical
device company, today announced that it plans to release financial
results for the third quarter 2017 after market close on Monday, October
30, 2017. Brad Mason, Chief Executive Officer, and Doug Rice, Chief
Financial Officer, will host a conference call and webcast to review the
Company's results at 4:30 p.m. ET the same day.
Interested parties may access the conference call by dialing (844)
809-1992 in the U.S. and (612) 979-9886 outside the U.S., and
referencing the conference ID 2078866. A replay of the call will be
available for two weeks by dialing (855) 859-2056 in the U.S. and (404)
537-3406 outside the U.S., and entering the conference ID 2078866. A
webcast of the conference call may be accessed by going to the Company's
by clicking on the Investors link and then the Events and Presentations
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units: BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the Company's sales representatives and distributors. In addition,
Orthofix is collaborating on research and development activities with
leading clinical organizations such as Brown University, Sinai Hospital
of Baltimore, Cleveland Clinic, Texas Scottish Rite Hospital for
Children, and the Musculoskeletal Transplant Foundation. For more
information, please visit www.orthofix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171019006406/en/
Orthofix International N.V.
Denise Landry, 214-937-2529
Source: Orthofix International N.V.
News Provided by Acquire Media